Artificial Intelligence

Description

Healthcare professionals and researchers are increasingly using artificial intelligence across different medical fields, for instance in diagnostics, radiology, research, clinical trials, generative AI-based solutions for workflow and patient information management. Artificial intelligence has the potential to facilitate patient diagnosis and care, and alleviate administrative burdens, but at the same time it also entails increased risks and burdens. Healthcare professionals are responsible for ensuring the quality of care to their patients and will therefore have increased responsibilities in oversight and validating results generated by AI.

The new AI Task Force allows medical societies, and the healthcare professionals and researchers that they represent, to exchange information and experiences with the use of AI in healthcare. A particular focus is on the regulatory framework, and particularly the implementation of the AI act and its impact on healthcare and research.

Chair

This Task Force is chaired by Merel Huisman.

Board Representatives

The Board Representatives for this task force is Tom Hemming Karlsen

Highlights

BioMed Alliance response to the call for evidence on the Digital Omnibus (Digital Package on Simplification)

On 14 October 2025, BioMed Alliance published a new document highlighting the recommendations of healthcare professionals and researchers on the digitalisation of healthcare and the simplification of the relevant regulatory framework. The document was based on an internal survey, and summarises medical societies views on the implementation of relevant legislations, the use of health data and AI in healthcare, and related challenges and opportunities. The document was prepared in the context of the European Commission’s call for evidence on the Digital Omnibus (Digital Package on Simplification). The Alliance underscores the urgent need to simplify digital rules in healthcare while upholding high safety standards. It calls for sector-specific guidance, regulatory clarity, and strong collaboration with healthcare professionals, patients, and researchers in shaping digital initiatives, including the European Health Data Space (EHDS) and the Artificial Intelligence Act (AI Act). Reforms must be forward-looking and designed to empower, not burden, those at the forefront of care and research, promoting the sustainable use of digital health and AI innovation.

16 October 2025Read more

Join us for the BioMed Alliance policy session on Artificial Intelligence in healthcare

AI & Healthcare: a match made in heaven? The use of Artificial Intelligence in healthcare is significantly increasing, with promising new developments that are transforming healthcare. AI has enormous potential to enhance patient care and facilitate health research, but there are also challenges and risks ahead. Join us on 29 November from 13.30-15.00 for an online discussion on the future of healthcare and the integration of AI in clinical practice and health research. At the occasion of the BioMed Alliance General Assembly, a series of interesting speakers will share their experience and knowledge on the use of AI & the regulatory framework that intends to facilitate the development and use of AI technologies, while mitigating risks. There will also be time for questions and reflection on what the future will look like, and how we can ensure that clinicians, healthcare professionals and patients are part of the transition. Speakers:

Dr. Angela Spatharou (EMEA Lead for Healthcare & Life Sciences, IBM, and EIT Health Supervisory Board member)
Dr. Gerard R. Dawson (CEO & CSO P1vital LTD and ECNP)
Salvatore Scalzo (Policy and Legal Officer AI Policy, DG CNECT, European Commission)
Prof. Frank Rademakers (Emeritus Professor Cardiology KU Leuven and CORE-MD)

The session is open to all upon registration here. More information is available on the agenda.

24 November 2021Read more

See all News See all resources